drugset / Trial / NCT05345717
Novel Desensitization Kidney Transplantation
NaSingle-groupOpen-labelTreatment
Summary
This proposal's objective is to determine whether belatacept, in conjunction with a proteasome inhibitor can be used to safely increase the likelihood of finding an acceptable donor for highly HLA sensitized kidney transplant candidates.
Timeline
- Start
- 2022-05-01
- Primary completion
- 2025-09-12
- Completion
- 2025-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belatacept | Protein / enzyme biologic | — | — |